Criteria for evaluating nonquantitative assays: application to serum choriogonadotropin.
We present guidelines for assessing the performance of nonquantitative (qualitative) assay methods. Criteria to be evaluated include analytical sensitivity, imprecision near limits of detection, analytical specificity, accuracy over a wide range of analyte concentrations, potential interferents, and technical ease of performance. A protocol was developed to evaluate several nonquantitative assay kits for detection of human choriogonadotropin (hCG) in serum. These include Tandem Icon HCG (Hybritech), Quest Pregnancy Test (Quidel), Concep-7 beta hCG (Leeco), and Beta Quik V (Pacific Biotech). Quantitative measurement of beta-hCG by RIA (Immophase beta hCG, Corning Medical) was used as the reference method. Results of this evaluation are discussed. The guidelines established and utilized in this report are adaptable to the evaluation of assay kits that measure other analytes by qualitative techniques.
D006063:Chorionic Gonadotropin / Q000097:blood*; D003951:Diagnostic Errors; D004797:Enzyme-Linked Immunosorbent Assay / Q000592:standards; D005260:Female; D006801:Humans; D011247:Pregnancy; D011258:Pregnancy Tests / Q000592:standards*; D011786:Quality Control; D011863:Radioimmunoassay / Q000592:standards; D011933:Reagent Kits, Diagnostic / Q000592:standards*; D012015:Reference Standards
D006063:Chorionic Gonadotropin; D011933:Reagent Kits, Diagnostic